[1] |
CALIÒ A N, BRUNELLI M, GOBBO S, et al. Cathepsin K: a novel diagnostic and predictive biomarker for renal tumors[J]. Cancers,2021,13(10):2441. doi: 10.3390/cancers13102441 |
[2] |
DAI R C, WU Z T, CHU H Y, et al. Cathepsin K: the action in and beyond bone[J]. Front Cell Dev Biol,2020,8:433. doi: 10.3389/fcell.2020.00433 |
[3] |
LI Z Q, HOU W S, ESCALANTE-TORRES C R, et al. Collagenase activity of cathepsin K depends on complex formation with chondroitin sulfate[J]. J Biol Chem,2002,277(32):28669-28676. doi: 10.1074/jbc.M204004200 |
[4] |
国家药典委员会. 中华人民共和国药典一部: 2020年版[M]. 北京: 中国医药科技出版社, 2020. |
[5] |
梁文娜, 李西海, 胡柳, 等. 二至丸抑制绝经后骨质疏松大鼠骨代谢紊乱的作用机制研究[J]. 中医正骨, 2017, 29(11):1-7,14. doi: 10.3969/j.issn.1001-6015.2017.11.001 |
[6] |
胡科. 二至丸对骨质疏松性股骨颈骨折术后愈合及髋关节功能的影响[J]. 现代中西医结合杂志, 2017, 26(4):384-386. doi: 10.3969/j.issn.1008-8849.2017.04.014 |
[7] |
俞益火, 陈久毅, 王建. 二至丸治疗绝经后骨质疏松症的疗效观察[J]. 中国中医骨伤科杂志, 2011(4):42-43. |
[8] |
蔡秀江, 黄美艳, 丁安伟, 等. 二至丸考源及药理作用研究进展[J]. 中国实验方剂学杂志, 2011, 17(23):272-275. doi: 10.3969/j.issn.1005-9903.2011.23.080 |
[9] |
蒋益萍, 吴岩斌, 秦路平, 等. 墨旱莲组分中组织蛋白酶K非活性位点抑制剂研究[J]. 药学学报, 2017, 52(6):936-942. doi: 10.16438/j.0513-4870.2016-1234 |
[10] |
钟询龙, 王若伦, 段炼, 等. 基于UPLC/Q-TOF-MS技术分析女贞子与墨旱莲配伍协同增效的物质基础[J]. 中国医院药学杂志, 2017, 37(19):1887-1891. doi: 10.13286/j.cnki.chinhosppharmacyj.2017.19.02 |
[11] |
李雯, 庞旭, 韩立峰, 等. 中药墨旱莲化学成分研究[J]. 中国中药杂志, 2018, 43(17):3498-3505. doi: 10.19540/j.cnki.cjcmm.20180625.001 |
[12] |
刘美红, 邹峥嵘. 女贞子化学成分, 药理作用及药动学研究进展[J]. 热带亚热带植物学报, 2022(003):030.446-460. |
[13] |
SHARMA V, PANWAR P, O'DONOGHUE A J, et al. Structural requirements for the collagenase and elastase activity of cathepsin K and its selective inhibition by an exosite inhibitor[J]. Biochem J,2015,465(1):163-173. doi: 10.1042/BJ20140809 |
[14] |
XU D, LYU Y, CHEN X W, et al. Fructus Ligustri Lucidi ethanol extract inhibits osteoclastogenesis in RAW264.7 cells via the RANKL signaling pathway[J]. Mol Med Rep,2016,14(5):4767-4774. doi: 10.3892/mmr.2016.5849 |
[15] |
LIU Y Q, HONG Z L, ZHAN L B, et al. Wedelolactone enhances osteoblastogenesis by regulating Wnt/β-catenin signaling pathway but suppresses osteoclastogenesis by NF-κB/c-fos/NFATc1 pathway[J]. Sci Rep,2016,6:32260. doi: 10.1038/srep32260 |
[16] |
TEPEL C, BRÖMME D, HERZOG V, et al. Cathepsin K in thyroid epithelial cells: sequence, localization and possible function in extracellular proteolysis of thyroglobulin[J]. J Cell Sci, 2000, 113 Pt 24: 4487-4498. |
[17] |
VASSALLE C, IERVASI G. Cathepsin K: a classical bone biomarker in cardiovascular disease: the heart is not alone anymore[J]. Atherosclerosis,2013,228(1):36-37. doi: 10.1016/j.atherosclerosis.2013.01.042 |